TNF inhibitors reduce coronary artery disease risk in rheumatoid arthritis
From Cardiology News, 27 February 2014: Use of tumor necrosis factor–alpha inhibitors was associated with a significant reduction in the risk of coronary artery disease in patients with rheumatoid arthritis, particularly with longer term use of the drugs, in a retrospective cohort study. The study of 2,101 patients with incident RA diagnosed during 2001-2011 showed … Continue reading TNF inhibitors reduce coronary artery disease risk in rheumatoid arthritis
Bianca Nogrady 